[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646596":3},{"organization":4,"armGroups":7,"interventions":44,"overallOfficials":50,"centralContacts":50,"locations":71,"responsibleParty":88,"collaborators":50,"id":90,"slug":91,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":50,"eligibilityCriteria":96,"healthyVolunteers":97,"sex":98,"minAge":99,"maxAge":100,"enrollmentInfo":101,"targetDuration":50,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":50,"overallStatus":110,"whyStopped":50,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Daewon Pharmaceutical Co., Ltd.","INDUSTRY",[8,14,18,23,28,33,38],{"label":9,"type":10,"description":11,"interventionNames":12},"cohort 1 (DW4421S 5mg)","EXPERIMENTAL","DW4421S-T0, 1 tablet will be orally administered in BID for 7days",[13],"Drug: DW4421S-T0",{"label":15,"type":10,"description":16,"interventionNames":17},"cohort 2 (DW4421S 10mg)","DW4421S-T0, 1 tablet will be orally administered in QD for 7days",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"cohort 3 (DW4421S 15mg)","DW4421S-T2, 1 tablet will be orally administered in QD for 7days",[22],"Drug: DW4421S-T2",{"label":24,"type":10,"description":25,"interventionNames":26},"cohort 4 (DW4421S 20mg)","DW4421S-T1, 1 tablet will be orally administered in QD for 7days",[27],"Drug: DW4421S-T1",{"label":29,"type":10,"description":30,"interventionNames":31},"cohort 5 (DW4421S 30mg)","DW4421S-T3, 1 tablet will be orally administered in QD for 7days",[32],"Drug: DW4421S-T3",{"label":34,"type":10,"description":35,"interventionNames":36},"cohort 6 (DW4421S 40mg)","DW4421S, 1 tablet will be orally administered in QD for 7days",[37],"Drug: DW4421S",{"label":39,"type":40,"description":41,"interventionNames":42},"cohort 7 (Zastaprazan 20mg)","ACTIVE_COMPARATOR","DW4421-3, 1 tablet will be orally administered in QD for 7days",[43],"Drug: DW4421-3",[45,51,55,59,63,67],{"type":46,"name":47,"description":48,"armGroupLabels":49,"otherNames":50},"DRUG","DW4421S-T0","DW4421 5mg",[9,15],null,{"type":46,"name":52,"description":53,"armGroupLabels":54,"otherNames":50},"DW4421S-T2","DW4421 15mg",[19],{"type":46,"name":56,"description":57,"armGroupLabels":58,"otherNames":50},"DW4421S-T1","DW4421 20mg",[24],{"type":46,"name":60,"description":61,"armGroupLabels":62,"otherNames":50},"DW4421S-T3","DW4421 30mg",[29],{"type":46,"name":64,"description":65,"armGroupLabels":66,"otherNames":50},"DW4421S","DW4421 40mg",[34],{"type":46,"name":68,"description":69,"armGroupLabels":70,"otherNames":50},"DW4421-3","Zastaprazan 20mg",[39],[72],{"facility":73,"status":50,"city":74,"state":75,"zip":50,"country":76,"countryCode":50,"cosmosGeoPoint":77,"geoPoint":82,"contacts":83},"Chungbuk National University Hospital","Cheongju-si","North Chungcheong","South Korea",{"type":78,"coordinates":79},"Point",[80,81],127.48972,36.63722,{"lat":81,"lon":80},[84],{"name":73,"role":85,"phone":86,"phoneExt":50,"email":87},"CONTACT","+82-43-269-6771","cbnuhirb@naver.com",{"type":89,"investigatorFullName":50,"investigatorTitle":50,"investigatorAffiliation":50,"oldNameTitle":50,"oldOrganization":50},"SPONSOR","100646596","phase-1-multiple-ascending-dose-study-of-dw4421-100646596",false,"NCT07691242","Multiple Ascending Dose Study of DW4421","A Phase 1 Clinical Trial to Evaluate the Safety, the Pharmacokinetics and Pharmacodynamics After Multiple Administration of DW4421 in Healthy Adult Volunteers","Inclusion Criteria:\n\n* Healthy adult aged 19 to 50 (inclusive) years, at the time of screening.\n* Subjects weighing between 50 kg and 90 kg with BMI between 18 and 27 kg\u002Fm2 (inclusive) at screening visit.\n\nExclusion Criteria:\n\n* Those who have clinical significant liver, kidney, nervous system, respiratory, endocrine, hematology and oncology, cardiovascular, urinary, and mental diseases or past history.",true,"ALL","19 Years","50 Years",{"count":102,"type":103},56,"ESTIMATED","INTERVENTIONAL",[106],"PHASE1","Multiple Ascending Dose of DW4421, phase I",[109],"Healthy Adult Volunteers","NOT_YET_RECRUITING","2026-07-02",{"date":113,"type":114},"2026-07-08","ACTUAL",{"date":116,"type":103},"2026-09",{"date":118,"type":103},"2027-02",{"name":5,"class":6},1]